Innovative Drugs of the 21st Century

Paper by RAS Academician A. G. Chuchalin*

Research Institute of Pulmonology, Federal Medical and Biological Agency of Russia, Moscow, Russia

e-mail: chuchalin@inbox.ru

Received January 14, 2016

Abstract—A real revolution is under way in the development of medicinal preparations. New-generation med-
icines are able to change the course of oncological and cardiovascular diseases, as well as type one and type
two diabetes mellitus. So-called “small molecules” are used to affect biological processes and monoclonal anti-
bodies, which are valuable tools to control cells that cause pathological processes. Target preparations are able
to identify damaged cells and destroy exclusively malignant neoplasms, not affecting healthy organs and tis-
sues. Individually selected drug-induced therapy contributes to quick improvement in the patient’s condition
and reduces considerably the risk of lethal outcome.

Keywords: monoclonal antibodies, biological targets, chronic noncommunicable diseases, beta blockers, hemo-
stasis, target drugs.

DOI: 10.1134/S1019331616030060

Pleiades Publishing home page | journal home page | top

If you have any problems with this server, contact webmaster.